U
DVAX

UBS’s Dynavax Technologies DVAX Stock Holding History

UBS’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-260
Closed -$5K – 10502
2013
Q4 		$5K Buy
+260
New +$3.81K ﹤0.01% 9539
2013
Q3 		– Sell
-600
Closed -$7K – 10425
2013
Q2 		$7K Buy
+600
New +$12.6K ﹤0.01% 8972

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

UBS's DVAX Position: Q3 2014 in Review

UBS reduced its Dynavax Technologies (DVAX) stake by 53% in Q3 2014, selling an estimated $23.8K and leaving 1,496 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #7947.

UBS first reported a position in DVAX in Q2 2013 and has held it in 6 quarters since. The position peaked at $149K in Q1 2014. 110 funds tracked by Wall St. Rank hold DVAX as of Q3 2014.

  • UBS held 1,496 shares of Dynavax Technologies worth $21K as of Q3 2014.
  • UBS sold 1,654 Dynavax Technologies shares in Q3 2014, an estimated $23.8K.
  • Dynavax Technologies made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7947 holding.
  • UBS first reported a position in Dynavax Technologies in Q2 2013 and has held it in 6 quarters since.
  • UBS's Dynavax Technologies position peaked at $149K in Q1 2014.
  • 110 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.